| Literature DB >> 30441749 |
Michelina Catauro1, Elisabetta Tranquillo2, Federico Barrino3, Ignazio Blanco4, Francesco Dal Poggetto5, Daniele Naviglio6.
Abstract
The use of oral iron integration is commonly recommended for the treatment of iron deficiency, nevertheless the diagnosis and treatment of this disease could clearly be improved. The aim of this work was the synthesis of therapeutic systems, iron (II) based, by sol-gel method. In an SiO₂ matrix, we embedded different weight percentages of polyethylene glycol (PEG6, 12, 24 wt%) and ferrous citrate (Fe(II)C5, 10, 15 wt%) for drug delivery applications. Fourier Transform Infrared (FTIR) spectroscopy was used to study the interactions among different components in the hybrid materials. Release kinetics in a simulated body fluid (SBF) were investigated and the amount of Fe2+ released was detected by Ultraviolet⁻Visible spectroscopy (UV-VIS) after reaction with ortho-phenantroline. Furthermore, the biological characterization was carried out. The bioactivity of the synthesized hybrid materials was evaluated by the formation of a layer of hydroxyapatite on the surface of samples soaked in SBF using FTIR spectroscopy. Finally, also, the potential antibacterial properties of the different materials against two different bacteria, E. coli and P. aeruginosa, were investigated.Entities:
Keywords: FTIR analysis; antibacterial properties; drug release; ferrous citrate; sol-gel
Year: 2018 PMID: 30441749 PMCID: PMC6266215 DOI: 10.3390/ma11112270
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Flow chart of sol-gel synthesis.
Figure 2Representative FTIR spectra of (a) pure PEG; (b) SiO2/PEG12 wt%/Fe(II)C5 wt%; (c)SiO2/PEG12 wt%/Fe(II)C10 wt%; (d) SiO2/PEG12 wt%/Fe(II)C15 wt%; (e) pure SiO2; (f) pure Fe(II)C.
Figure 3Calibration curve (520.0 nm) based on the concentration of Fe2+ (r2 = 0.9973).
Figure 4Time-dependent drug release plot for (A) SiO2/PEG6 wt%/Fe(II)C5 wt%; SiO2/PEG6 wt%/Fe(II)C15 wt%; SiO2/PEG6 wt%/Fe(II)C20 wt%; (B) SiO2/PEG12 wt%/Fe(II)C5 wt%; SiO2/PEG12 wt%/Fe(II)C10 wt%; SiO2/PEG12 wt%/Fe(II)C15 wt%; (C) SiO2/PEG24 wt%/Fe(II)C5 wt%; SiO2/PEG24 wt%/Fe(II)C10 wt%; SiO2/PEG24 wt%/Fe(II)C15 wt%. Data are presented as means ± SD for a representative experiment.
Figure 5Representative FTIR spectra of (a) SiO2/PEG12 wt%/Fe(II)C5 wt% not soaked in SBF; (b) SiO2/PEG12 wt%/Fe(II)C5 wt%; (c) SiO2/PEG12 wt%/Fe(II)C10 wt%; (d) SiO2/PEG12 wt%/Fe(II)C15 wt%; after 21 days of exposure to SBF.
Figure 6A representative XRD of SiO2/PEG12 wt%/Fe(II)C15 wt% soaked in SBF solution for 21 days.
Figure 7(A) Inhibition halo (ID) of E. coli with all materials; (B) Inhibition halo (ID) of P. aeruginosa with all materials; (C) Comparison of inhibition zone of E. coli and P. aeruginosa for all materials. Values are the mean SD of measurements carried out on samples analyzed three times. The means and S.D. are shown. *, p <0.05 vs the bacteria control treated with hybrids without Fe(II)C or vs the bacteria treated with hybrids containing Fe(II)C.